Advertisement
Screener

SCIENCE 37 HOLDINGS, INC. Selling, General and Administrative Expense

SCIENCE 37 HOLDINGS, INC. Selling, General and Administrative Expense

SCIENCE 37 HOLDINGS, INC. reported Selling, General and Administrative Expense of $14.74 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-07.

Discontinued › Expense Statement › Operating Expenses

us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2023-11-07

  • SCIENCE 37 HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2023-09-30 was $14.74M, a 39.80% decline year-over-year.
  • SCIENCE 37 HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2023-06-30 was $16.59M, a 41.12% decline year-over-year.
  • SCIENCE 37 HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2023-03-31 was $20.48M, a 32.08% decline year-over-year.
  • SCIENCE 37 HOLDINGS, INC. selling, general and administrative expense for the quarter ending 2022-12-31 was $20.43M, a 42.68% decline year-over-year.
  • SCIENCE 37 HOLDINGS, INC. selling, general and administrative expense for fiscal 2022 was $103.25M, a 41.21% increase from fiscal 2021.
  • SCIENCE 37 HOLDINGS, INC. selling, general and administrative expense for fiscal 2021 was $73.12M, a 157.92% increase from fiscal 2020.
  • SCIENCE 37 HOLDINGS, INC. selling, general and administrative expense for fiscal 2020 was $28.35M.
Period endSelling, General and Administrative Expense 3 monthSelling, General and Administrative Expense 6 monthSelling, General and Administrative Expense 9 monthSelling, General and Administrative Expense 12 month
2023-09-30$14.74M
10-Q · filed 2023-11-07
$31.33M
derived: sum of 2 quarters · filed 2023-11-07
$51.81M
10-Q · filed 2023-11-07
$72.25M
derived: sum of 4 quarters · filed 2023-11-07
2023-06-30$16.59M
10-Q · filed 2023-08-08
$37.07M
10-Q · filed 2023-08-08
$57.51M
derived: sum of 3 quarters · filed 2023-08-08
$81.99M
derived: sum of 4 quarters · filed 2023-11-07
2023-03-31$20.48M
10-Q · filed 2023-05-15
$40.91M
derived: sum of 2 quarters · filed 2023-05-15
$65.40M
derived: sum of 3 quarters · filed 2023-11-07
$93.58M
derived: sum of 4 quarters · filed 2023-11-07
2022-12-31$20.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$44.92M
derived: sum of 2 quarters · filed 2023-11-07
$73.10M
derived: sum of 3 quarters · filed 2023-11-07
$103.25M
10-K · filed 2023-03-06
2022-09-30$24.48M
10-Q · filed 2023-11-07
$52.67M
derived: sum of 2 quarters · filed 2023-11-07
$82.82M
10-Q · filed 2023-11-07
$118.47M
derived: sum of 4 quarters · filed 2023-11-07
2022-06-30$28.18M
10-Q · filed 2023-08-08
$58.34M
10-Q · filed 2023-08-08
$93.98M
derived: sum of 3 quarters · filed 2023-08-08
$110.91M
derived: sum of 4 quarters · filed 2023-08-08
2022-03-31$30.15M
10-Q · filed 2023-05-15
$65.80M
derived: sum of 2 quarters · filed 2023-05-15
$82.73M
derived: sum of 3 quarters · filed 2023-05-15
$94.11M
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31$35.65M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06
$52.58M
derived: sum of 2 quarters · filed 2023-03-06
$63.96M
derived: sum of 3 quarters · filed 2023-03-06
$73.12M
10-K · filed 2023-03-06
2021-09-30$16.93M
10-Q · filed 2022-11-10
$28.31M
derived: sum of 2 quarters · filed 2022-11-10
$37.48M
10-Q · filed 2022-11-10
2021-06-30$11.38M
10-Q · filed 2022-08-11
$20.55M
10-Q · filed 2022-08-11
2021-03-31$9.16M
10-Q · filed 2022-05-09
2020-12-31$28.35M
10-K · filed 2022-03-22